PAHO has published the first evidence-based guide to the treatment of tungiasis, a disease caused by the sand flea Tunga penetrans. The parasite burrows into the skin and produces intense inflammation, pain, burning and itching, most often on the feet. Children and older adults are most affected and the condition can lead to chronic complications, severe deformities and social stigma.
PAHO’s regional advisor on neglected infectious diseases, Ana Luciañez, said the disease affects communities living in poverty and marginalisation. The guidelines recommend low-viscosity dimethicone as the preferred treatment because it kills fleas, is easy to use and is less expensive than surgical removal. If dimethicone is not available, the guide recommends ivermectin.
The guide warns against removing the parasite without antiseptic measures or trained personnel. Manual removal is common and often done with needles, scissors or hairpins. The guide also discourages potassium permanganate and hydrogen peroxide because they can cause burns, dark pigmentation or skin irritation. PAHO urges combined clinical, community and environmental measures and better awareness among patients, health workers and authorities.
Difficult words
- tungiasis — A disease caused by a flea that hurts.
- flea — A small insect that jumps and bites.
- pain — Uncomfortable feeling in the body.
- guidelines — Instructions on how to do something.
- surgical — Related to medical operations.
- awareness — Knowledge about a particular issue.
- complications — Problems that make a situation worse.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why is it important to seek medical care for tungiasis?
- What else can communities do to help those affected by tungiasis?
- How can education help health workers in treating this disease?
Related articles
Many pesticides used in Latin America are banned in the EU
A study found that many active pesticide ingredients allowed on major crops in eight Latin American countries are banned or not authorised in the EU. The researchers examined public approval records up to December 2020 and warn of health risks.
Blocking a key immune signal may prolong post-surgery pain
A study led by Geoffroy Laumet found that blocking the immune molecule TNF-α after surgery in mice made pain last longer. The authors warn this does not mean stopping all anti-inflammatory treatment and call for targeted approaches.